(Q68816691)

English

Enhancement of cytotoxic and proliferative responses of lymphocytes from melanoma patients by incubation with monoclonal antibodies against ganglioside GD3

scientific article published on 01 January 1987

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

Enhancement of cytotoxic and proliferative responses of lymphocytes from melanoma patients by incubation with monoclonal antibodies against ganglioside GD3 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

P Hersey

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

M MacDonald

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

C Burns

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

D A Cheresh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

144-150

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot trial of murine monoclonal antibodies in patients with advanced melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal expansion of human B73.1-positive natural killer cells or large granular lymphocytes exerting strong antibody-dependent and -independent cytotoxicity and occasionally lectin-dependent cytotoxicity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human malignant melanoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two Distinct Cytotoxic T Lymphocyte Subpopulations in Patients with Vogt-Koyanagi-Harada Disease that Recognize Human Melanoma Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melanoma antibodies: specificity and interaction with melanoma and cytotoxic T-cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The characterization and function of human immunoregulatory T lymphocyte subsets

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3

1 reference

https://pubmed.ncbi.nlm.nih.gov/3493846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00205592

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3493846%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68816691&oldid=2218623970"